This comparative review examines retatrutide and tirzepatide, evaluating how retatrutide’s triple-receptor agonism (GLP-1, GIP, and glucagon) differs mecha
Read more Retatrutide vs. Tirzepatide: How Triple Agonism Compares to Dual Agonism
Survodutide is an investigational dual GLP-1 and glucagon receptor agonist undergoing clinical evaluation for obesity and metabolic dysfunction-associated
Read more Survodutide Studies: Evaluating Dual GLP-1 and Glucagon Agonism in Clinical Research
An evidence-based scientific review of survodutide (BI 456906), exploring its dual GLP-1 and glucagon receptor agonism, Phase 2 trial results in MASH and o
Read more Survodutide: Mechanism of Action and Clinical Trial Evidence